DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,053 filers reported holding DANAHER CORPORATION in Q2 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $821,774 | +1.1% | 3,257 | +6.4% | 0.41% | +3.3% |
Q4 2022 | $812,950 | +2.8% | 3,060 | 0.0% | 0.39% | -2.7% |
Q3 2022 | $791,000 | +1.8% | 3,060 | 0.0% | 0.40% | +5.5% |
Q2 2022 | $777,000 | -14.2% | 3,060 | -0.9% | 0.38% | +8.2% |
Q1 2022 | $906,000 | -13.6% | 3,089 | -3.1% | 0.36% | +19.9% |
Q4 2021 | $1,049,000 | +8.0% | 3,189 | 0.0% | 0.30% | -0.7% |
Q3 2021 | $971,000 | -21.2% | 3,189 | -30.5% | 0.30% | -19.2% |
Q2 2021 | $1,232,000 | -2.6% | 4,590 | -18.3% | 0.37% | -5.4% |
Q1 2021 | $1,265,000 | +3.0% | 5,620 | +1.6% | 0.39% | -11.2% |
Q4 2020 | $1,228,000 | +3.1% | 5,530 | 0.0% | 0.44% | -12.0% |
Q3 2020 | $1,191,000 | +17.7% | 5,530 | -3.4% | 0.50% | -4.6% |
Q2 2020 | $1,012,000 | +15.0% | 5,725 | -10.0% | 0.52% | -37.7% |
Q1 2020 | $880,000 | -22.5% | 6,360 | -14.0% | 0.84% | +34.2% |
Q4 2019 | $1,135,000 | -18.6% | 7,395 | -23.4% | 0.63% | -29.8% |
Q3 2019 | $1,394,000 | +0.6% | 9,655 | -0.4% | 0.89% | +2.5% |
Q2 2019 | $1,386,000 | +7.4% | 9,695 | -0.8% | 0.87% | +0.2% |
Q1 2019 | $1,290,000 | +28.0% | 9,775 | 0.0% | 0.87% | +8.5% |
Q4 2018 | $1,008,000 | +4.2% | 9,775 | -13.3% | 0.80% | -3.5% |
Q3 2017 | $967,000 | +7.6% | 11,275 | +5.8% | 0.83% | -0.1% |
Q2 2017 | $899,000 | -1.5% | 10,655 | -0.1% | 0.83% | -1.1% |
Q1 2017 | $913,000 | +8.7% | 10,670 | -1.1% | 0.84% | +3.2% |
Q4 2016 | $840,000 | – | 10,790 | – | 0.81% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |